<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32479602</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Jul</Month><Day>09</Day></PubDate></JournalIssue><Title>Nucleic acids research</Title><ISOAbbreviation>Nucleic Acids Res</ISOAbbreviation></Journal><ArticleTitle>FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention.</ArticleTitle><Pagination><StartPage>6889</StartPage><EndPage>6905</EndPage><MedlinePgn>6889-6905</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkaa410</ELocationID><Abstract><AbstractText>Mutations in the RNA-binding protein FUS cause amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease. FUS plays a role in numerous aspects of RNA metabolism, including mRNA splicing. However, the impact of ALS-causative mutations on splicing has not been fully characterized, as most disease models have been based on overexpressing mutant FUS, which will alter RNA processing due to FUS autoregulation. We and others have recently created knockin models that overcome the overexpression problem, and have generated high depth RNA-sequencing on FUS mutants in parallel to FUS knockout, allowing us to compare mutation-induced changes to genuine loss of function. We find that FUS-ALS mutations induce a widespread loss of function on expression and splicing. Specifically, we find that mutant FUS directly alters intron retention levels in RNA-binding proteins. Moreover, we identify an intron retention event in FUS itself that is associated with its autoregulation. Altered FUS levels have been linked to disease, and we show here that this novel autoregulation mechanism is altered by FUS mutations. Crucially, we also observe this phenomenon in other genetic forms of ALS, including those caused by TDP-43, VCP and SOD1 mutations, supporting the concept that multiple ALS genes interact in a regulatory network.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Humphrey</LastName><ForeName>Jack</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCL Genetics Institute, University College London, London WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birsa</LastName><ForeName>Nicol</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milioto</LastName><ForeName>Carmelo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLaughlin</LastName><ForeName>Martha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ule</LastName><ForeName>Agnieszka M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robaldo</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eberle</LastName><ForeName>Andrea B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, Bern 3012,&#xa0;Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kr&#xe4;uchi</LastName><ForeName>Rahel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, Bern 3012,&#xa0;Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bentham</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Anna-Leigh</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCL Genetics Institute, University College London, London WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarvis</LastName><ForeName>Seth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCL Genetics Institute, University College London, London WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bodo</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garone</LastName><ForeName>Maria G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Sapienza University of Rome, Rome 00185, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devoy</LastName><ForeName>Anny</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, London SE5 9RT,&#xa0;UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soraru</LastName><ForeName>Gianni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Universit&#xe0; degli Studi di Padova,&#xa0;Padova 35121, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosa</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sapienza University of Rome, Rome 00185, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Life Nano Science, Istituto Italiano di Tecnologia, Rome 00161, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozzoni</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sapienza University of Rome, Rome 00185, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Life Nano Science, Istituto Italiano di Tecnologia, Rome 00161, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>Elizabeth M C</ForeName><Initials>EMC</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;hlemann</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, Bern 3012,&#xa0;Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiavo</LastName><ForeName>Giampietro</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Discoveries Centre for Regenerative and Precision Medicine, University College London Campus, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruepp</LastName><ForeName>Marc-David</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, London SE5 9RT,&#xa0;UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isaacs</LastName><ForeName>Adrian M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plagnol</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>UCL Genetics Institute, University College London, London WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fratta</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/S022708/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/M008606/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S006508/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>FRATTA/JAN15/946-795</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>ISAACS/APR15/834-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>PLAGNOL/OCT15/885-792</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>107116/Z/15/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>FISHER/APR14/874-792</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.6</RegistryNumber><NameOfSubstance UI="C000614178">VCP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.6</RegistryNumber><NameOfSubstance UI="D000074405">Valosin Containing Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007438" MajorTopicYN="N">Introns</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073658" MajorTopicYN="N">Loss of Function Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012326" MajorTopicYN="N">RNA Splicing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074405" MajorTopicYN="N">Valosin Containing Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32479602</ArticleId><ArticleId IdType="pmc">PMC7337901</ArticleId><ArticleId IdType="doi">10.1093/nar/gkaa410</ArticleId><ArticleId IdType="pii">5849905</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor J.P., Brown R.H. Jr, Cleveland D.W.. Decoding ALS: from genes to mechanism. Nature. 2016; 539:197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E. et al. .. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008; 319:1668&#x2013;1672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De&#xa0;Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P. et al. .. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009; 323:1208&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Lagier-tourenne C., Hutt K.R., Stephanie C., Moran J., Liang T.Y., Ling S.-C., Sun E., Wancewicz E., Mazur C. et al. .. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011; 14:459&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.-C., Liang T.Y., Mazur C. et al. .. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012; 15:1488&#x2013;1497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogelj B., Easton L.E., Bogu G.K., Stanton L.W., Rot G., Curk T., Zupan B., Sugimoto Y., Modic M., Haberman N. et al. .. Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci. Rep. 2012; 2:603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3429604</ArticleId><ArticleId IdType="pubmed">22934129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigaki S., Masuda A., Fujioka Y., Iguchi Y., Katsuno M., Shibata A., Urano F., Sobue G., Ohno K.. Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions. Sci. Rep. 2012; 2:529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3402842</ArticleId><ArticleId IdType="pubmed">22829983</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda A., Takeda J.-I., Okuno T., Okamoto T., Ohkawara B., Ito M., Ishigaki S., Sobue G., Ohno K.. Position-specific binding of FUS to nascent RNA regulates mRNA length. Genes Dev. 2015; 29:1045&#x2013;1057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4441052</ArticleId><ArticleId IdType="pubmed">25995189</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.-C., Polymenidou M., Cleveland D.W.. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013; 79:416&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang P.-M., Ling J., Jeong Y.H., Price D.L., Aja S.M., Wong P.C.. Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc. Natl. Acad. Sci. U.S.A. 2010; 107:16320&#x2013;16324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2941284</ArticleId><ArticleId IdType="pubmed">20660762</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y., Katsuno M., Niwa J.I., Takagi S., Ishigaki S., Ikenaka K., Kawai K., Watanabe H., Yamanaka K., Takahashi R. et al. .. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain. 2013; 136:1371&#x2013;1382.</Citation><ArticleIdList><ArticleId IdType="pubmed">23449777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wils H., Kleinberger G., Janssens J., Pereson S., Joris G., Cuijt I., Smits V., Ceuterick-de&#xa0;Groote C., Van&#xa0;Broeckhoven C., Kumar-Singh S.. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. U.S.A. 2010; 107:3858&#x2013;3863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2840518</ArticleId><ArticleId IdType="pubmed">20133711</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan X., P.-M. C., Price D.L., Wong P.C.. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 2010; 107:16325&#x2013;16330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2941282</ArticleId><ArticleId IdType="pubmed">20736350</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I., Bell S., Cairns N.J., Miller T.M., Baloh R.H.. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. U.S.A. 2009; 106:18809&#x2013;18814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Skibinski G., Korb E., Rao E.J., Wu J.Y., Finkbeiner S.. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J. Neurosci. 2010; 30:639&#x2013;649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2821110</ArticleId><ArticleId IdType="pubmed">20071528</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold E.S., S.-C. L., Huelga S.C., Lagier-Tourenne C., Polymenidou M., Ditsworth D., Kordasiewicz H.B., McAlonis-Downes M., Platoshyn O., Parone P.A. et al. .. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc. Natl. Acad. Sci. U.S.A. 2013; 110:E736&#x2013;E745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Hicks G.G., Singh N., Nashabi A., Mai S., Bozek G., Klewes L., Arapovic D., White E.K., Koury M.J., Oltz E.M. et al. .. Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat. Genet. 2000; 24:175&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pubmed">10655065</ArticleId></ArticleIdList></Reference><Reference><Citation>Kino Y., Washizu C., Kurosawa M., Yamada M., Miyazaki H., Akagi T., Hashikawa T., Doi H., Takumi T., Hicks G.G. et al. .. FUS/TLS deficiency causes behavioral and pathological abnormalities distinct from amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2015; 3:24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4408580</ArticleId><ArticleId IdType="pubmed">25907258</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbeeck C., Deng Q., DeJesus-Hernandez M., Taylor G., Ceballos-Diaz C., Kocerha J., Golde T., Das P., Rademakers R., Dickson D.W. et al. .. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis. Mol. Neurodegener. 2012; 7:53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3519790</ArticleId><ArticleId IdType="pubmed">23046583</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J.C., McGoldrick P., Vance C., Hortobagyi T., Sreedharan J., Rogelj B., Tudor E.L., Smith B.N., Klasen C., Miller C.C.J. et al. .. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 2013; 125:273&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiihashi G., Ito D., Yagi T., Nihei Y., Ebine T., Suzuki N.. Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice. Brain. 2016; 139:2380&#x2013;2394.</Citation><ArticleIdList><ArticleId IdType="pubmed">27368346</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu H., Lee S., Shang Y., Wang W.Y., Au K.F., Kamiya S., Barmada S.J., Finkbeiner S., Lui H., Carlton C.E. et al. .. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J. Clin. Invest. 2014; 124:981&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3938263</ArticleId><ArticleId IdType="pubmed">24509083</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Lyashchenko A.K., Lu L., Nasrabady S.E., Elmaleh M., Mendelsohn M., Nemes A., Tapia J.C., Mentis G.Z., Shneider N.A.. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 2016; 7:10465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala Y.M., Conti L.D., Dhir A., Romano M., Ambrogio A.D., Tollervey J., Ule J., Baralle M., Baralle F.E., De&#xa0;Conti L. et al. .. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 2011; 30:277&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3025456</ArticleId><ArticleId IdType="pubmed">21131904</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Liu S., Liu G., &#xd6;zt&#xfc;rk A., Hicks G.G.. ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLos Genet. 2013; 9:e1003895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3814325</ArticleId><ArticleId IdType="pubmed">24204307</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P., Sivakumar P., Humphrey J., Lo K., Ricketts T., Oliveira H., Brito-Armas J.M., Kalmar B., Ule A., Yu Y. et al. .. Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis. EMBO J. 2018; 37:e98684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5983119</ArticleId><ArticleId IdType="pubmed">29764981</ArticleId></ArticleIdList></Reference><Reference><Citation>White M.A., Kim E., Duffy A., Adalbert R., Phillips B.U., Peters O.M., Stephenson J., Yang S., Massenzio F., Lin Z. et al. .. TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD. Nat. Neurosci. 2018; 21:552&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5884423</ArticleId><ArticleId IdType="pubmed">29556029</ArticleId></ArticleIdList></Reference><Reference><Citation>Devoy A., Kalmar B., Stewart M., Park H., Burke B., Noy S.J., Redhead Y., Humphrey J., Lo K., Jaeger J. et al. .. Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in 'FUSDelta14&#x2019; knockin mice. Brain. 2017; 140:2797&#x2013;2805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5841203</ArticleId><ArticleId IdType="pubmed">29053787</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang Y., Huang E.J.. Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis. Brain Res. 2016; 1647:65&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003642</ArticleId><ArticleId IdType="pubmed">27033831</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Rodde R., Edbauer D., Bentmann E., Fischer I., Hruscha A., Than M.E., MacKenzie I.R.A., Capell A., Schmid B. et al. .. ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. EMBO J. 2010; 29:2841&#x2013;2857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P., Isaacs A.M.. The snowball effect of RNA binding protein dysfunction in amyotrophic lateral sclerosis. Brain. 2018; 141:1236&#x2013;1238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5917769</ArticleId><ArticleId IdType="pubmed">29701791</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J., Sendscheid O., Oussini H.E., Jambeau M., Ying S.. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. EMBO J. 2016; 35:1077&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4868956</ArticleId><ArticleId IdType="pubmed">26951610</ArticleId></ArticleIdList></Reference><Reference><Citation>Capauto D., Colantoni A., Lu L., Santini T., Peruzzi G., Biscarini S., Morlando M., Shneider N.A., Caffarelli E., Laneve P. et al. .. A regulatory circuitry between gria2, miR-409, and miR-495 is affected by als fus mutation in ESC-derived motor neurons. Mol. Neurobiol. 2018; 55:7635&#x2013;7651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6132778</ArticleId><ArticleId IdType="pubmed">29430619</ArticleId></ArticleIdList></Reference><Reference><Citation>Luisier R., Tyzack G.E., Hall C.E., Mitchell J.S., Devine H., Taha D.M., Malik B., Meyer I., Greensmith L., Newcombe J. et al. .. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS. Nat. Commun. 2018; 9:2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5964114</ArticleId><ArticleId IdType="pubmed">29789581</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E., Sandoe J., Williams L.A., Boulting G.L., Moccia R., Wainger B.J., Han S., Peng T., Thams S., Mikkilineni S. et al. .. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell. 2014; 14:781&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Yang Y.-C.T., Huang Y., Zhu Y., Lu Z.J.. POSTAR: a platform for exploring post-transcriptional regulation coordinated by RNA-binding proteins. Nucleic Acids Res. 2017; 45:D104&#x2013;D114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5210617</ArticleId><ArticleId IdType="pubmed">28053162</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V., Hinz F.I., Rexach J.E., Noguchi K.-I., Toyoshiba H., Oda A., Hirai K., Sarkar A., Seyfried N.T., Cheng C. et al. .. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. Nat. Med. 2019; 25:152&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6602064</ArticleId><ArticleId IdType="pubmed">30510257</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Belzil V.V., Batra R., Ross C.A., Gendron T.F., Pregent L.J., Murray M.E., Overstreet K.K., Piazza-Johnston A.E., Desaro P. et al. .. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat. Neurosci. 2015; 18:1175&#x2013;1182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y., Hochberg Y.. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 1995; 57:289&#x2013;300.</Citation></Reference><Reference><Citation>Katz Y., Wang E.T., Airoldi E.M., Burge C.B.. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat. Methods. 2010; 7:1009&#x2013;1015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3037023</ArticleId><ArticleId IdType="pubmed">21057496</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarti A.M., Haberman N., Praznik A., Luscombe N.M., Ule J.. Data science issues in studying Protein&#x2013;RNA interactions with CLIP technologies. Ann. Rev. Biomed. Data Sci. 2018; 1:235&#x2013;261.</Citation></Reference><Reference><Citation>Pollard K.S., Hubisz M.J., Rosenbloom K.R., Siepel A.. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 2010; 20:110&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2798823</ArticleId><ArticleId IdType="pubmed">19858363</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Payer B., Namekawa S., An J.Y., Press William, Catalan-Dibene J., Sunwoo H., Lee J.T.. Xist imprinting is promoted by the hemizygous (unpaired) state in the male germ line. Proc. Natl. Acad. Sci. U.S.A. 2015; 112:14415&#x2013;14422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4664331</ArticleId><ArticleId IdType="pubmed">26489649</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards C.R., Ritchie W., Wong J.J.-L., Schmitz U., Middleton R., An X., Mohandas N., Rasko J.E.J., Blobel G.A.. A dynamic intron retention program in the mammalian megakaryocyte and erythrocyte lineages. Blood. 2016; 127:e24&#x2013;e34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4850870</ArticleId><ArticleId IdType="pubmed">26962124</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson P., Joncourt R., M&#xfc;hlemann O.. Analysis of nonsense-mediated mrna decay in mammalian cells. Curr. Protoc. Cell Biol. 2012; 55:27.4.1&#x2013;27.4.61.</Citation><ArticleIdList><ArticleId IdType="pubmed">22733442</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak K.J., Schmittgen T.D.. Analysis of relative gene expression data using real-time quantitative PCR and the 2&#x2212;&#x394;&#x394;CT Method. Methods. 2001; 25:402&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco D.A., Lemay N., Ko H.K., Zhou H., Burke C., Kwiatkowski T.J., Sapp P., Mckenna-Yasek D., Brown R.H., Hayward L.J.. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum. Mol. Genet. 2010; 19:4160&#x2013;4175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2981014</ArticleId><ArticleId IdType="pubmed">20699327</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Restagno G., Brunetti M., Ossola I., Calvo A., Mora G., Sabatelli M., Monsurr&#xf2; M.R., Battistini S., Mandrioli J. et al. .. Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation. Neurobiol. Aging. 2009; 30:1272&#x2013;1275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2771748</ArticleId><ArticleId IdType="pubmed">19450904</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J., Oussini H.E., Mersmann S., Drenner K., Wagner M., Sun Y., Allmeroth K., Dieterl&#xe9; S., Sinniger J., Dirrig-Grosch S. et al. .. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis. Acta Neuropathol. 2017; 133:887&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5427169</ArticleId><ArticleId IdType="pubmed">28243725</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Chi B., Xia W., Gangopadhyay J., Yamazaki T., Winkelbauer-Hurt M.E., Yin S., Eliasse Y., Adams E., Shaw C.E. et al. .. U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish. Nucleic Acids Res. 2015; 43:3208&#x2013;3218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4381066</ArticleId><ArticleId IdType="pubmed">25735748</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Reed R.. FUS functions in coupling transcription to splicing by mediating an interaction between RNAP II and U1 snRNP. Proc. Natl. Acad. Sci. U.S.A. 2015; 112:8608&#x2013;8613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4507187</ArticleId><ArticleId IdType="pubmed">26124092</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling J.P., Pletnikova O., Troncoso J.C., Wong P.C.. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 2015; 349:650&#x2013;655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J., Emmett W., Fratta P., Isaacs A.M., Plagnol V.. Quantitative analysis of cryptic splicing associated with TDP-43 depletion. BMC Med. Genomics. 2017; 10:38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5446763</ArticleId><ArticleId IdType="pubmed">28549443</ArticleId></ArticleIdList></Reference><Reference><Citation>Lareau L.F., Inada M., Green R.E., Wengrod J.C., Brenner S.E.. Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature. 2007; 446:926&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pubmed">17361132</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni J.Z., Grate L., Donohue J.P., Preston C., Nobida N., O&#x2019;Brien G., Shiue L., Clark T.A., Blume J.E., Ares M.. Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay. Genes Dev. 2007; 21:708&#x2013;718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1820944</ArticleId><ArticleId IdType="pubmed">17369403</ArticleId></ArticleIdList></Reference><Reference><Citation>Dredge B.K., Stefani G., Engelhard C.C., Darnell R.B.. Nova autoregulation reveals dual functions in neuronal splicing. EMBO J. 2005; 24:1608&#x2013;1620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1142566</ArticleId><ArticleId IdType="pubmed">15933722</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossbach O., Hung L.-H., Schreiner S., Grishina I., Heiner M., Hui J., Bindereif A.. Auto- and Cross-Regulation of the hnRNP L Proteins by Alternative Splicing. Mol. Cell. Biol. 2009; 29:1442&#x2013;1451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2648227</ArticleId><ArticleId IdType="pubmed">19124611</ArticleId></ArticleIdList></Reference><Reference><Citation>Wollerton M.C., Gooding C., Wagner E.J., Garcia-Blanco M.A., Smith C.W.J.. Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay. Mol. Cell. 2004; 13:91&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">14731397</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenfeld N., Elowitz M.B., Alon U.. Negative autoregulation speeds the response times of transcription networks. J. Mol. Biol. 2002; 323:785&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">12417193</ArticleId></ArticleIdList></Reference><Reference><Citation>Jangi M., Boutz P.L., Paul P., Sharp P.A.. Rbfox2 controls autoregulation in RNA-binding protein networks Rbfox2 controls autoregulation in RNA-binding protein networks. Genes Dev. 2014; 28:637&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3967051</ArticleId><ArticleId IdType="pubmed">24637117</ArticleId></ArticleIdList></Reference><Reference><Citation>McGlincy N.J., Smith C.W.J.. Alternative splicing resulting in nonsense-mediated mRNA decay: what is the meaning of nonsense. Trends Biochem. Sci. 2008; 33:385&#x2013;393.</Citation><ArticleIdList><ArticleId IdType="pubmed">18621535</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutz P.L., Bhutkar A., Sharp P.A.. Detained introns are a novel, widespread class of post-transcriptionally spliced introns. Genes Dev. 2015; 29:63&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4281565</ArticleId><ArticleId IdType="pubmed">25561496</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazal F.M., Han S., Parker K.R., Kaewsapsak P., Xu J., Boettiger A.N., Chang H.Y., Ting A.Y.. Atlas of subcellular RNA localization revealed by APEX-Seq. Cell. 2019; 178:473&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6786773</ArticleId><ArticleId IdType="pubmed">31230715</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter M.S., Doskow J., Morris P., Li S., Nhim R.P., Sandstedt S., Wilkinson M.F.. A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro. J. Biol. Chem. 1995; 270:28995&#x2013;29003.</Citation><ArticleIdList><ArticleId IdType="pubmed">7499432</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.-C., Dastidar S.G., Tokunaga S., Ho W.Y., Lim K., Ilieva H., Parone P.A., Tyan S.-H., Tse T.M., Chang J.-C. et al. .. Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis. Elife. 2019; 8:e40811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6389288</ArticleId><ArticleId IdType="pubmed">30747709</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukavsky P.J., Daujotyte D., Tollervey J.R., Ule J., Stuani C., Buratti E., Baralle F.E., Damberger F.F., Allain F.H.-T.. Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43. Nat. Struct. Mol. Biol. 2013; 20:1443&#x2013;1449.</Citation><ArticleIdList><ArticleId IdType="pubmed">24240615</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall C.E., Yao Z., Choi M., Tyzack G.E., Serio A., Luisier R., Harley J., Preza E., Arber C., Crisp S.J. et al. .. Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS. Cell Rep. 2017; 19:1739&#x2013;1749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5464993</ArticleId><ArticleId IdType="pubmed">28564594</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M. et al. .. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314:130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergeron D., Pal G., Beaulieu Y.B., Chabot B., Bachand F.. Regulated intron retention and nuclear Pre-mRNA decay contribute to PABPN1 autoregulation. Mol. Cell. Biol. 2015; 35:2503&#x2013;2517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4475927</ArticleId><ArticleId IdType="pubmed">25963658</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob A.G., Smith C.W.J.. Intron retention as a component of regulated gene expression programs. Hum. Genet. 2017; 136:1043&#x2013;1057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5602073</ArticleId><ArticleId IdType="pubmed">28391524</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama A., Sugai A., Kato T., Ishihara T., Shiga A., Toyoshima Y., Koyama M., Konno T., Hirokawa S., Yokoseki A. et al. .. Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43. Nucleic Acids Res. 2016; 44:5820&#x2013;5836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4937342</ArticleId><ArticleId IdType="pubmed">27257061</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohagheghi F., Prudencio M., Stuani C., Cook C., Jansen-West K., Dickson D.W., Petrucelli L., Buratti E.. TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor. Hum. Mol. Genet. 2016; 25:534&#x2013;545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4731020</ArticleId><ArticleId IdType="pubmed">26614389</ArticleId></ArticleIdList></Reference><Reference><Citation>Huelga S.C., Vu A.Q., Arnold J.D., Liang T.Y., Liu P.P., Yan B.Y., Donohue J.P., Shiue L., Hoon S., Brenner S. et al. .. Integrative Genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins. Cell Rep. 2012; 1:167&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3345519</ArticleId><ArticleId IdType="pubmed">22574288</ArticleId></ArticleIdList></Reference><Reference><Citation>Gueroussov S., Weatheritt R.J., O&#x2019;Hanlon D., Lin Z.Y., Narula A., Gingras A.C., Blencowe B.J.. Regulatory expansion in mammals of multivalent hnRNP assemblies that globally control alternative splicing. Cell. 2017; 170:324&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">28709000</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticozzi N., Vance C., LeClerc A.L., Keagle P., Glass J.D., McKenna-Yasek D., Sapp P.C., Silani V., Bosco D.A., Shaw C.E. et al. .. Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2011; 156:285&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">21438137</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J., Hart M.P., Erion R., King O.D., Diaz Z., Nakaya T., Ibrahim F., Kim H.J., Mojsilovic-petrovic J., Panossian S. et al. .. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2012; 21:2899&#x2013;2911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3373238</ArticleId><ArticleId IdType="pubmed">22454397</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Pratt G.A., Vu A.Q., Hutt K.R., Martinez F.J., Sundararaman B., Batra R., Freese P., Lambert N.J., Huelga S.C. et al. .. Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat. Commun. 2016; 7:12143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4935974</ArticleId><ArticleId IdType="pubmed">27378374</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton C.F., Good S.K., Atkin S., Dewey C.M., Mayer P. III, Herz J., Yu G.. TDP-43 is a developmentally regulated protein essential for early embryonic development. J. Biol. Chem. 2010; 285:6826&#x2013;6834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2825476</ArticleId><ArticleId IdType="pubmed">20040602</ArticleId></ArticleIdList></Reference><Reference><Citation>Cragnaz L., Klima R., De&#xa0;Conti L., Romano G., Feiguin F., Buratti E., Baralle M., Baralle F.E.. An age-related reduction of brain TBPH/TDP-43 levels precedes the onset of locomotion defects in a Drosophila ALS model. Neuroscience. 2015; 311:415&#x2013;421.</Citation><ArticleIdList><ArticleId IdType="pubmed">26518462</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack G.E., Luisier R., Taha D.M., Neeves J., Modic M., Mitchell J.S., Meyer I., Greensmith L., Newcombe J., Ule J. et al. .. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis. Brain. 2019; 142:2572&#x2013;2580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6735815</ArticleId><ArticleId IdType="pubmed">31368485</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu E.Y., Russ J., Cali C.P., Phan J.M., Amlie-Wolf A., Lee E.B.. Loss of nuclear TDP-43 is associated with decondensation of LINE retrotransposons. Cell Rep. 2019; 27:1409&#x2013;1421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6508629</ArticleId><ArticleId IdType="pubmed">31042469</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>